Medical University of South Carolina, Charleston, SC, USA.
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Investig Clin Urol. 2017 Jun;58(Suppl 1):S23-S31. doi: 10.4111/icu.2017.58.S1.S23. Epub 2017 May 24.
The work-up of a febrile urinary tract infection is generally performed to detect vesicoureteral reflux (VUR) and its possible complications. The imaging modalities most commonly used for this purpose are renal-bladder ultrasound, voiding cystourethrogram and dimercapto-succinic acid scan. These studies each contribute valuable information, but carry individual benefits and limitations that may impact their efficacy. Biochemical markers are not commonly used in pediatric urology to diagnose or differentiate high-risk disease, but this is the emerging frontier, which will hopefully change our approach to VUR in the future. As it becomes more apparent that there is tremendous clinical variation within grades of VUR, the need to distinguish clinically significant from insignificant disease grows. The unfortunate truth about VUR is that recommendations for treatment may be inconsistent. Nuances in clinical decision-making will always exist, but opinions for medical versus surgical intervention should be more standardized, based on risk of injury to the kidney.
发热性尿路感染的检查通常用于检测膀胱输尿管反流 (VUR) 及其可能的并发症。为此目的最常使用的成像方式是肾脏-膀胱超声、排尿性膀胱尿道造影和二巯丁二酸扫描。这些研究各自提供了有价值的信息,但也有各自的优势和局限性,可能会影响其效果。在小儿泌尿科中,生化标志物通常不用于诊断或区分高危疾病,但这是一个新兴的领域,有望在未来改变我们对 VUR 的治疗方法。随着 VUR 分级内存在巨大临床差异变得越来越明显,区分有临床意义和无临床意义疾病的需求也在增加。VUR 的不幸事实是,治疗建议可能不一致。临床决策中的细微差别总是存在的,但基于对肾脏损伤的风险,医疗与手术干预的意见应该更加标准化。